Bardy Diagnostics Stock

bardydx.comHealthcareFounded: 1900Funding to Date: $84.02MM

Bardy Diagnostics is the developer of a heart monitor known as Carnation Ambulatory Monitor (CAM™) that can be worn comfortably and discreetly for up to 14 days.

Register for Details

For more details on financing and valuation for Bardy Diagnostics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Bardy Diagnostics.

Register Today


Management Team

Mark Querry
Chief Financial Officer
Ken Nelson
Chief Commercial Officer
Gust Bardy MD
Founder, Chief Executive Officer, Chief Medical Officer and Chairman
Jonathan Wu
Director, Marketing
Alan Levy Ph.D
Executive Director
Edward Vertatschitsch Ph.D
Chief Operating Officer
Mark Handfelt
Chief Operating Officer

Board Members

David Tamburri
LaViolette Paul
Warren Watson
Garheng Kong MD
HealthQuest Capital
Rubal Bedi
Ascension Ventures
Gerry Brunk
Lumira Ventures
Gust Bardy MD
Rurik Vandevenne
River Cities Capital Funds

Other companies like Bardy Diagnostics in the Healthcare sector

Last Round Est. Valuation
Last Round Est. Valuation
Last Round Est. Valuation
Last Round Est. Valuation
Last Round Est. Valuation


/PRNewswire/ -- Bardy Diagnostics, Inc., ("BardyDx"), a leading provider of ambulatory cardiac monitoring technologies and custom data solutions, including the...
Bardy Diagnostics, a Seattle-based business developing a cardiac monitor and arrhythmia detection device, announced this week it has raised $35.5 million